SMT

Sahajanand Medical Technologies Limited

Listed company · ISIN INE356Y01018 · NSE EQ · FV ₹1
Last price
₹526
+7.83%today
What this company does

Sahajanand Medical Technologies Limited is a listed company. It booked ₹373 cr of revenue in its latest quarter (Q2 FY27) and kept 6.9% of sales as profit.

53out of 100
Equitytale Health Score
Mixed

Healthier than 53% of listed companies we score, on the 4 of 6 measures we could read for it. Each measure is ranked against the 2,403–2,943 companies that reported it.

Measures financial condition, not whether to buy. Learn what this score means · How this is calculated

Profitability & returns64

How much profit it earns on the money it employs

Balance sheet49

How much it owes, and whether earnings cover the interest

Valuation18

What today's price implies, against our models or its peers

Governance & risk86

How much of the promoters' stake is pledged, and how much they hold

Not measurable for this company: cash quality, growth & consistency. Those pillars are left out of the score rather than counted as zero.

Is this company doing well?
not investment advice
A mixed picture
Strengths
✓ Makes a profit
✓ No promoter shares pledged
✓ Turns profit into real cash
Watch-outs
! Thin 6.9% net margin

What if I invest in SMT?

Set a growth rate and see what a monthly SIP would add up to. Your assumption, our arithmetic.

You would put in
₹12.00 lakh
120 instalments
At 10% a year, it would become
₹20.15 lakh

The starting rate is a round number, not a view on this company — this is your assumption, and the figure above is arithmetic on it. Returns are not steady year to year, and a real holding would not grow in a straight line. We do not publish price targets or predict returns.

Key ratios · latest quarter + price
₹526▲ +7.83%
latest close · 2026-11-06
52-wk low ₹34711 sessions so far52-wk high ₹566
Is it cheap or expensive?
What you pay for the profits, book value and cash flow. Higher isn't automatically worse — it can signal faster growth.
P/E ratio50.0High
LowAverageHigh
P/B ratio7.00High
Below bookModerateHigh
EV / EBITDA19.9High
LowAverageHigh
How good is the business?
How much profit it earns from its money and its sales.
Return on equity14.0%Fair
WeakFairStrong ▸15%
Return on capital22.1%Strong
WeakFairStrong
Net margin6.9%Decent
ThinDecentStrong
EBITDA margin18.2%Decent
ThinDecentHealthy
Is it financially safe?
How much it owes, and whether it can comfortably cover it.
Debt to equity0.40Comfortable
LowModerateHigh ▸1
Interest cover6.9×Strong
RiskyOkayStrong ▸5×
Current ratio1.79Healthy
Tight ◂1HealthyAmple
More figures
Market cap
₹5,161 cr
Book value
₹75
EPS
₹2.63
latest quarter
Net debt
₹224 cr
owes more than its cash
Enterprise value
₹5,385 cr
EBITDA
₹271 cr
annualised
EBIT
₹188 cr
annualised
Operating margin
12.6%
Return on assets
7.8%
Earnings yield
2.00%
P/S
3.46
Sales / share
₹152.2
Tax rate
33.9%
Face value
₹1
Shares
9.8 cr
Working capital
₹379 cr
Current assets
₹856 cr
Current liabilities
₹477 cr
Delivery %
21.1%
Strong / safeFairWeak / riskyValuation — a level, not good/badBands are general rules of thumb, not advice.

P/E, ROE, ROCE and margins are annualised from the latest quarter; per-share and balance-sheet ratios use the most recent balance sheet on file · prices as of 2026-11-06.

P&L · Q2 FY27 (consolidated)
Revenue from Operations₹373 cr
Other Income₹2 cr
Total Income₹376 cr
Cost of Materials₹80 cr
Purchases of Stock-in-Trade₹34 cr
Inventory Change (±)₹-18 cr
Employee Benefit Expense₹101 cr
Finance Costs₹7 cr
Depreciation & Amortisation₹21 cr
Other Expenses₹111 cr
Total Expenses₹336 cr
Profit before Tax₹40 cr
Tax Expense₹14 cr
Net Profit₹26 cr
Net margin on total income7.0%
Where the money goes · Q2 FY27
% of total income
Materials + stock-in-trade₹96 cr25.5%
Employee benefit expense₹101 cr27.0%
Finance costs₹7 cr1.8%
Depreciation & amortisation₹21 cr5.6%
Other expenses₹111 cr29.5%
Tax expense₹14 cr3.6%
Profit for the period₹26 cr7.0%
Total income ₹376 cradds up to ₹100 ✓
Balance sheet & cash flow · as of Sep 2026
Low debt
Total assets
₹1,326 cr
Shareholder equity
₹737 cr
parent shareholders
Total debt
₹302 cr
Cash
₹78 cr
Cash flow · H1 FY27
Operating
₹47 cr
Investing
₹-40 cr
Financing
₹-3 cr
Who owns it · 2026-10-22
No pledge
Promoter
36.2%
FII / Foreign
35.1%
DII / Domestic
11.8%
Retail / others
13.4%
Smart-money activity
Bulk / block deals
SoldMICROCURVES TRADING PRIVATE LIMITED · NSE5.75 L @ ₹502.0128 Oct 26
BoughtMICROCURVES TRADING PRIVATE LIMITED · NSE5.75 L @ ₹501.6428 Oct 26
BoughtJUMP TRADING FINANCIAL INDIA PRIVATE LIMITED · NSE5.70 L @ ₹515.6528 Oct 26
Who controls this company, and what it pays them

Most Indian companies are controlled by a family or group — the promoters. The exchange requires them to be listed by name, including members who own no shares at all, and requires the company to disclose any business it does with them.

The promoter group — 28 named members
owning 36.1% between them · as of 2026-10-22
Shree Hari Trust34.05%
Dhirajkumar Savjibhai Vasoya2.05%
Jitendra Vallabhbhai Kotadia0.03%
Alka Manojkumar Rabadiano shares
Anusar Incno shares
ARK Trustno shares
Arunaben Ravjibhai Bhuvano shares
Bhargav Dhirajlal Kotadiano shares

Names and holdings from the company’s shareholding pattern filed with the exchange; transactions from the related-party note in its annual report. Every figure is as filed — these are legal, disclosed dealings, and what to make of them is your call.

How the stock has moved · adjusted for splits & bonuses
Data from primary exchange filings · analysis tool, not investment advice.